Hopp til innhold
Close

Get alerts of updates about «Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2016»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2016

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Report

Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2016

Published

The annual report from Resistance against Antivirals in Norway (RAVN) presents national surveillance data on antiviral resistance for the following viruses: Influenza virus, HIV-1, hepatitis B virus, cytomegalovirus and herpes simplex virus.

RAVN-rapport 2016_Forside_web.jpg

The annual report from Resistance against Antivirals in Norway (RAVN) presents national surveillance data on antiviral resistance for the following viruses: Influenza virus, HIV-1, hepatitis B virus, cytomegalovirus and herpes simplex virus.


Order

Download:

Summary

This fourth report also comprises some relevant topics in the field: New preventive treatment of HIV-infection, novel therapy strategies of hepatitis B and next-generation sequences of hepatitis C virus.

The report is available in English.

Downloadable

About this publication

  • Year: September 2017
  • By: Folkehelseinstituttet
  • Authors RAVN.
  • ISBN (digital): 978-82-8082-860-6